Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$213.86 - $277.87 $529,303 - $687,728
-2,475 Reduced 5.71%
40,884 $9.58 Million
Q1 2022

May 18, 2022

BUY
$259.82 - $298.18 $11.3 Million - $12.9 Million
43,359 New
43,359 $11.4 Million
Q4 2021

Feb 03, 2022

SELL
$271.6 - $314.21 $11.4 Million - $13.2 Million
-42,074 Closed
0 $0
Q3 2021

Nov 04, 2021

BUY
$274.82 - $308.34 $2.07 Million - $2.32 Million
7,536 Added 21.82%
42,074 $11.8 Million
Q2 2021

Aug 05, 2021

BUY
$251.87 - $278.14 $8.7 Million - $9.61 Million
34,538 New
34,538 $9.53 Million
Q2 2019

Jul 23, 2019

SELL
$144.16 - $172.9 $22.1 Million - $26.5 Million
-153,430 Closed
0 $0
Q1 2019

May 07, 2019

SELL
$123.7 - $156.3 $17.6 Million - $22.3 Million
-142,537 Reduced 48.16%
153,430 $23.5 Million
Q4 2018

Feb 01, 2019

SELL
$120.82 - $174.09 $14 Million - $20.2 Million
-115,823 Reduced 28.13%
295,967 $37.4 Million
Q3 2018

Nov 19, 2018

BUY
$167.67 - $188.27 $52.7 Million - $59.2 Million
314,363 Added 322.67%
411,790 $71.5 Million
Q2 2018

Jul 26, 2018

SELL
$160.33 - $189.41 $32.1 Million - $37.9 Million
-200,000 Reduced 67.24%
97,427 $53.4 Million
Q2 2018

Jul 26, 2018

BUY
$160.33 - $189.41 $1.61 Million - $1.91 Million
10,060 Added 3.5%
297,427 $53.4 Million
Q1 2018

May 15, 2018

SELL
$161.53 - $178.11 $2.55 Million - $2.82 Million
-15,815 Reduced 5.22%
287,367 $46.5 Million
Q4 2017

Feb 12, 2018

BUY
$147.99 - $163.95 $11.6 Million - $12.8 Million
78,285 Added 34.81%
303,182 $48.4 Million
Q3 2017

Nov 09, 2017

SELL
$149.47 - $160.56 $17.5 Million - $18.8 Million
-116,910 Reduced 34.2%
224,897 $34 Million
Q2 2017

Aug 11, 2017

BUY
N/A
341,807
341,807 $52.7 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Sawgrass Asset Management LLC Portfolio

Follow Sawgrass Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.